Mumbai: Ransomware attacks and IP and data theft are the top cybersecurity concerns for pharma companies in India as they take the digital leap, a new report showed on Thursday.<\/p>\n\n\n\n
The pandemic and a rising number of targeted attacks have prompted certain pharma companies to double their cybersecurity investments, according to the report by Deloitte India-Data Security Council of India (DSCI).<\/p>\n\n\n\n
“To be able to scale this digital vision and create trust globally, the pharma sector must recognise cybersecurity as a key lever, working towards bolstering security around data, operational technologies (OT), and across the supply chain,” said Gaurav Shukla, Partner and Leader, Cyber, Deloitte India.<\/p>\n\n\n\n
“This ability to utilise cybersecurity as a key enabler for business and digital transformation can help pharma organisations make the transition from a leader to a trusted leader,” Shukla added.<\/p>\n\n\n\n
For leading pharma companies, cybersecurity investments have increased by a minimum of 25 to 30 per cent between 2019 and 2021.<\/p>\n\n\n\n
The pandemic and the rising number of targeted attacks have prompted certain pharma companies to double their cybersecurity investments over the past 18 months.<\/p>\n\n\n\n
Furthermore, 70 per cent of the leading pharma companies highlighted their focus on a zero-trust approach with the need for a clear roadmap over the next two years, around network, data, and access, the report mentioned.<\/p>\n\n\n\n
“While production linked incentive (PLI) schemes and government support will encourage more niche manufacturers and research-led organisations, the focus on cybersecurity adoption and effectively managing cyber risks will enable business transformation and establish market leaders in this sector,” said Rama Vedashree, CEO, DSCI.<\/p>\n","protected":false},"excerpt":{"rendered":"
Mumbai: Ransomware attacks and IP and data theft are the top cybersecurity concerns for pharma companies in India as they take the digital leap, a new report showed on Thursday. The pandemic and a rising number of targeted attacks have prompted certain pharma companies to double their cybersecurity investments, according to the report by Deloitte […]<\/p>\n","protected":false},"author":1,"featured_media":275686,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-275685","post","type-post","status-publish","format-standard","has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/posts\/275685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/comments?post=275685"}],"version-history":[{"count":0,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/posts\/275685\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/media\/275686"}],"wp:attachment":[{"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/media?parent=275685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/categories?post=275685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nagalandpost.net\/index.php\/wp-json\/wp\/v2\/tags?post=275685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}